Scientific Literature Search

Source record

First therapy targeting Parkinson's proteins enters clinical trials.

Dolgin E.

Nat Med · 2012-07-06

DOI: 10.1038/nm0712-992bPMID: 22772533

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Mathematical insights into the effects of levodopa.

Reed MC, Nijhout HF, Best JA.

Front Integr Neurosci · 2012-07-04

DOI: 10.3389/fnint.2012.00021PMID: 22783173

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cognitive-behavioral therapy for pathological gambling in Parkinson's disease: a pilot controlled study.

Jiménez-Murcia S, Bove FI, Israel M, Steiger H, Fernández-Aranda F, Alvarez-Moya E, Granero R, Penelo E, Vergé B, Aymamí MN, Santamaría JJ, Gómez-Peña M, Moragas L, Savvidou LG, Menchón JM.

Eur Addict Res · 2012-07-03

DOI: 10.1159/000337442PMID: 22760081

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Adjunctive therapy in Parkinson's disease: the role of rasagiline.

Gaines KD, Hinson VK.

Neuropsychiatr Dis Treat · 2012-07-02

DOI: 10.2147/ndt.s25142PMID: 22802692

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes.

Fujita K, Yamafuji M, Nakabeppu Y, Noda M.

Oxid Med Cell Longev · 2012-07-01

DOI: 10.1155/2012/324256PMID: 22811764

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res · 2012-07-01

DOI: 10.2174/156720512801322564PMID: 21875407

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dyskinesia in Parkinson disease - an unmet therapeutic challenge.

Debicki D, Jog M.

Can J Neurol Sci · 2012-07-01

DOI: 10.1017/s0317167100013925PMID: 22728848

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis.

Elahi B, Phielipp N, Chen R.

Can J Neurol Sci · 2012-07-01

DOI: 10.1017/s0317167100013974PMID: 22728853

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease.

Nishikawa N, Nagai M, Tsujii T, Iwaki H, Yabe H, Nomoto M.

Clin Neuropharmacol · 2012-07-01

DOI: 10.1097/wnf.0b013e3182575cdbPMID: 22751085

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?

Citrome L.

Clin Schizophr Relat Psychoses · 2012-07-01

PMID: 22776634

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease.

Oswal A, Litvak V, Sauleau P, Brown P.

J Neurosci · 2012-07-01

DOI: 10.1523/jneurosci.0275-12.2012PMID: 22815506

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Levodopa microparticles for pulmonary delivery: photodegradation kinetics and LC stability-indicating method.

Pereira RL, Paim CS, Barth AB, Raffin RP, Guterres SS, Schapoval EE.

Pharmazie · 2012-07-01

PMID: 22888517

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.728 articles found

First therapy targeting Parkinson's proteins enters clinical trials.

Mathematical insights into the effects of levodopa.

Cognitive-behavioral therapy for pathological gambling in Parkinson's disease: a pilot controlled study.

Adjunctive therapy in Parkinson's disease: the role of rasagiline.

Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Dyskinesia in Parkinson disease - an unmet therapeutic challenge.

N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis.

Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease.

Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?

Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease.

Levodopa microparticles for pulmonary delivery: photodegradation kinetics and LC stability-indicating method.

Filters